118 Atypical haemolytic uraemic syndrome in the era of complement inhibiting therapy: The UK national cohort experience (2023)

First Author: Brocklebank V
Attributed to:  Understanding the Properdin Paradox using C3 D1115N (gain-of-function) knock-in mice funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.imbio.2023.152569

Publication URI: http://dx.doi.org/10.1016/j.imbio.2023.152569

Type: Journal Article/Review

Parent Publication: Immunobiology

Issue: 5